EventHealthAugust 27, 2026

Ai2 and Providence Swedish partner to advance AI-assisted cancer discovery

AutoDiscovery uncovered a stronger immune signature in invasive lobular breast cancer, validated across an independent dataset and lab analysis. The finding suggests ~15% of US breast cancer patients could benefit from immunotherapy. The partnership includes a local deployment to keep clinical data secure.

Featured · Kelly Paulson, Bodhisattwa Majumder

3 sources

Daily brief

Get tomorrow's AI brief in your inbox

More stories today

Open the live feed